485PWithholding Anti-EGFR: Impact on outcome of RAS wild-type metastatic colorectal tumours (WAIT OR ACT): A multicentric AGEO study. (23rd October 2018) - Palmieri, L-J; Mineur, L; Tougeron, D; Rousseau, B J-C; Granger, V; Gornet, J-M; Smith, D; Lievre, A; Galais, M P; Racine Doat, S; Pernot, S; Bignon Bretagne, A L; et al.